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Abstract: In the present study, the chemical investigation of the leaves of Annona reticulata 
has resulted in the identification of nine compounds, including annonaretin A, (1), a new 
triterpenoid. The purified compounds were subjected to the examination of their effects on 
NO inhibition in LPS-activated mouse peritoneal macrophages and most of them exhibited 
significant NO inhibition, with IC50 values in the range of 48.6 ± 1.2 and 99.8 ± 0.4 μM. 
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1. Introduction 
The Annona genus (Annonaceae) consists of about 119 species, most of which are shrubs and trees 
widely distributed in the tropical and subtropical regions, including the Southeast Asia countries such 
as Malaysia, Indonesia, Thailand, Cambodia, Laos, and Vietnam. In Indian folk medicine, various 
species of Annona have been used as vermifuges, anti-inflammatory agents, in wound healing, as 
antimalarial agents and in the treatment of diarrhoea and dysentery [1]. The bark of the plant Annona 
reticulata L. is a powerful astringent and given as tonic. The plant has been used as an anti-inflammatory 
agent in wound healing, anti-anxiety, anti-stress, anti-mutagenic, and spasmolytic agent. Leaf and stem 
extract shows inotropic, positive chronotropic and spasmolytic activities [2]. The plant is reported to 
contain acetogenins mainly cis- and trans-isomurisolenin [3], annoreticuin, bullatacin, squamosine, 
rolliniastatin [4], reticullacinone, rolliniastatin-2, molvizarin [5], 14-hydroxy-25-deoxy-rollinicin [6]. 
Reticulatacin and kaurane diterpenes were also identified from the bark of the plant [7]. Other terpenes 
such as spathenelol, muurolene, copaene and eudesmol were reported in the previous literature [8]. In 
our continued program aimed at the identification of anti-inflammatory drug leads from natural 
sources, the chemical composition of the leaves of A. reticulata was investigated to search for the 
bioactive constituents by assays of inhibitory effects on NO inhibition in LPS-activated mouse 
peritoneal macrophages. In the present study, we wished to report the characterization of nine compounds, 
including the structural determination of new compound 1, as well as their NO inhibitory effects. 
2. Results and Discussion 
2.1. Isolation and Characterization of Compounds 
Air-dried and powdered leaves of A. reticulata L. were soaked with methanol at room temperature, 
and the combined extracts were concentrated to give a deep brown syrup. The crude extract was 
suspended into water and partitioned with n-hexane, ethyl acetate, and n-butanol, successively to 
afford n-hexane, ethyl acetate, n-butanol, and water solubles, respectively. Purification of the n-hexane 
soluble fraction by column chromatography yielded annonaretin A (1) (Figure 1), kaurenoic acid (2) [9], 
taraxerol (3) [10], β-sitosterol (4) [11], 16α-hydro-19-al-ent-kauran-17-oic acid (5) [9],   
6β-hydroxystigmast-4-en-3-one (6) [12], and 17-acetoxy-16β-ent-kauran-19-oic acid 24 (7) [13]. 
Purification of the ethyl acetate soluble afforded 16α-hydro-ent-kauran-17,19-dioic acid (8) [9], and 
(2S)-di-O-methylquiritigenin (9) [14]. Compounds 2–9 (Figure 2) are known compounds, and their 
structures were identified by comparison of their physical and spectroscopic data with those reported 
in the literature. Compound 1 is new.  
2.2. Structural Elucidation of New Compound 1 
The purified colorless powder 1 was visualized by spraying with 1% (w/v) Ce(SO4)2 in 10% (v/v) 
aqueous H2SO4 followed by heating at 120 °C and displayed purplish black spots on TLC plate. It also 
displayed a positive response in the Lieberman–Burchard test. These results suggested that compound 
1 possessed a basic triterpenoid skeleton [15]. The molecular formula of 1 was established as C33H56O3 
by the pseudomolecular [M+Na]
+ ion peak at m/z 523.4122 in HR-ESI-MS analysis and was further Molecules 2013, 18 4479 
 
 
supported by its 
13C-NMR spectrum which showed signals for all 33 carbons of the molecule, 
including one set of terminal methylenes (δC 111.9, 147.4), three oxygenated carbons (δC 62.8, 71.0, 
83.2), and seven methyl carbons (δC 15.1, 18.1, 19.0, 19.3, 20.7, 21.3, 25.7). In the 
1H-NMR spectrum 
of 1, there were five singlets at δ 0.82 (3H, s, CH3-18), 0.91 (3H, s, CH3-21), 0.97 (3H, s, CH3-22), 
0.98 (3H, s, CH3-19), and 1.60 (3H, s, CH3-30); and two doublets at δ 0.80 (3H, d, J = 9.5 Hz, CH3-32) 
and 0.93 (3H, d, J = 6.0 Hz, CH3-33), respectively. In addition, two high field cyclopropyl proton 
doublets at δ 0.40 (1H, d, J = 4.5 Hz, H-20) and 0.62 (1H, d, J = 4.5 Hz, H-20) evidenced that this 
compound was a triterpenoid derivative with the cycloartanol skeleton. In the downfield region, four 
oxygenated protons at δ 3.01 (1H, d, J = 9.5 Hz, H-3), 3.54 (1H, dd, J = 11.0, 6.0 Hz, H-24), 3.64 (1H, 
br dd, J = 16.0, 9.0 Hz, H-2), and 3.70 (1H, br d, J = 11.0 Hz, H-24) were located at C-2, -3, and -24 
determined by the 
2J, 
3J-HMBC correlations through H-2 to C-3 (δ 83.2), C-4 (δ 40.3); H-3 to C-1  
(δ 25.7), C-2 (δ 71.0), C-4, and C-18 (δ 15.1); and H-24 to C-23 (δ 46.2), C-25 (δ 27.7), respectively. 
The position of terminal methylene group at δ 4.64 (1H, br s, H-29) and 4.77 (1H, br s, H-29) was also 
establsihed with the HMBC analysis of correlations between H-29 and C-27 (δ 55.4), C-30 (δ 19.0). In 
the HMBC spectral analysis (Figure 2), correlation peaks between H-32 and C-33, C-31, C-27; H-33 
and C-32, C-31, C-27, supported that one isopropyl group was attached at C-27. The high field doublets 
at δ 0.40 and 0.62 displayed HMBC correlations with the carbons at δ 25.7 (C-1), 39.7 (C-11), and 47.1 
(C-5) also confirmed the presence of cyclopropyl functionality as C-20 connected with C-9 and C-10. 
The full assignments of 
1H- and 
13C-NMR signals were substantiated by extensive 2D NMR 
experimental analysis. Therefore the chemical structure of 1 was established as shown in Figure 1 and 
the compound was given the trivial name annonaretin A. 
Figure 1. Structure and significant HMBC (→) correlations of compound 1. 
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Figure 2. Structures of purified known compounds 2–9. 
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2.3. The Inhibitory Effects of Isolated Compounds on NO Production 
The isolated compounds 1–9 were subjected into the examination of their effects on LPS-induced 
iNOS-dependent NO production in RAW 264.7 cells. Cells cultured with 1–9 at different 
concentrations used in the presence of 100 ng/mL LPS for 24 h (Table 1). Some cell toxicity was 
observed in cells treated with compounds 1, 2, 4, and 9, whereas other compounds had no influence on 
cell viability. NO production was significantly decreased by the treatment with 2, 3, and 5–8 in a dose-
dependent manner, with IC50 values in the range of 48.6 ± 1.2 and 99.8 ± 0.4 μM (Table 1). The 
inhibitory effects of 1, 4 and 9 were less obvious. 2, 3, and 5–8 did not exhibit significant cytotoxicity 
in the concentration range of 12.5–100 μM (Table 1), thus the NO inhibiting effects were probably not 
due to cytotoxicity. Among the tested compounds, 2, and 5–8 belonged to the ent-kaurane diterpenoids 
noted for the occurrence in the Annona species [16,17]. In the previous literature, kaurenoic acid (2) 
was reported to inhibit NO production, prostaglandin E2 release, cyclooxygenase-2, and inducible 
nitric oxide synthase expression in LPS-induced RAW264.7 macrophages [18]. It also exhibited   
anti-inflammatory [19,20], cytotoxic [21,22], antiplasmodial [21], antimicrobial [16], hypoglycaemic [23], 
vasorelaxant [24,25], and antispasmodic [25] bioactivities. 16α-Hydro-19-al-ent-kauran-17-oic acid (5) 
displayed the most significant inhibitory effect on NO production with the lowest IC50 value of   
48.6 ± 1.2 μM. It was also reported from the stems of A. squamosa to exhibit anti-platelet aggregation Molecules 2013, 18 4481 
 
 
activity [26]. In addition, taraxerol (3) could downregulate the expression of proinflammatory 
mediators in macrophages by interfering with the activation of TAK1 and Akt, thus preventing NF-κB 
activation [27]. In our experimental results, 2, 3, and 5 displayed NO inhibitory effects similar to these 
anti-inflammatory reports. 
Table 1. Inhibitory effects of purified samples from the leaves of A. reticulata on LPS-induced 
iNOS-dependent NO production in RAW 264.7 cells. 
 Dose  (μM) 
Cell viability 
(% of control) 
NO level 
NO inhibition 
(% of control) 
IC50 
(μM) 
Control (−)  100.0 ± 4.9  −0.5 ± 0.1  (−) (−) 
LPS  (+)  98.7 ± 8.0  45.4 ± 2.7 
### ( −) (−) 
1  12.5 
25 
50 
100 
88.0 ± 1.5 
81.2 ± 1.8 
73.0 ± 3.6 * 
66.9 ± 5.5 ** 
36.6 ± 1.9 
33.5 ± 0.9 
(−) 
(−) 
19.3 ± 4.2 
26.2 ± 2.0 
(−) 
(−) 
(−) 
2  12.5 
25 
50 
100 
98.0 ± 2.2 
91.0 ± 3.6 
82.9 ± 1.2 
65.7 ± 8.6 ** 
34.3 ± 4.7 
35.1 ± 1.2 
22.7 ± 0.5 ** 
(−) 
24.5 ± 10.2 
22.7 ± 2.6 
50.0 ± 1.0 
(−) 
50.0 ± 0.3 
 
3  12.5 
25 
50 
100 
93.5 ± 1.8 
92.6 ± 3.1 
88.7 ± 1.8 
81.4 ± 2.3 
38.5 ± 2.3 
39.5 ± 0.6 
35.6 ± 0.9 * 
22.6 ± 0.4 ** 
15.2 ± 5.0 
13.1 ± 1.2 
21.6 ± 2.0 
50.1 ± 0.9 
99.8 ± 0.4 
 
4  12.5 
25 
50 
100 
82.8 ± 2.7 
80.7 ± 3.8 
65.3 ± 2.3 ** 
55.8 ± 2.7 ** 
38.4 ± 0.7 
38.6 ± 3.3 
(−) 
(−) 
15.5 ± 1.5 
15.1 ± 7.3 
(−) 
(−) 
(−) 
5  12.5 
25 
50 
100 
98.9 ± 5.2 
96.5 ± 9.2 
95.9 ± 8.6 
80.2 ± 5.7 
38.3 ± 1.3 
33.1 ± 1.0 * 
22.1 ± 1.5 ** 
14.8 ± 0.7 *** 
15.5 ± 2.8 
27.1 ± 2.3 
51.4 ± 3.2 
67.3 ± 1.5 
48.6 ± 1.2 
 
6  12.5 
25 
50 
100 
94.8 ± 3.1 
83.7 ± 3.5 
83.5 ± 3.0 
81.3 ± 2.8 
37.0 ± 1.8 
33.1 ± 2.4 * 
22.9 ± 1.1 ** 
15.1 ± 0.3 *** 
18.5 ± 4.0 
27.1 ± 5.3 
49.5 ± 2.4 
66.7 ± 0.6 
51.5 ± 0.5 
 
7  12.5 
25 
50 
100 
98.6 ± 3.1 
93.6 ± 4.0 
92.5 ± 2.8 
83.7 ± 1.6 
42.6 ± 0.7 
40.6 ± 2.8 
23.7 ± 0.2 ** 
14.3 ± 0.3 *** 
6.2 ± 1.5 
10.6 ± 6.1 
47.7 ± 0.3 
68.5 ± 0.7 
55.5 ± 0.3 
 
8  12.5 
25 
50 
100 
98.4 ± 3.2 
94.0 ± 2.6 
88.6 ± 2.6 
82.4 ± 1.2 
39.8 ± 1.2 
35.4 ± 0.8 * 
23.5 ± 0.9 ** 
14.4 ± 0.3 *** 
12.3 ± 2.6 
21.9 ± 1.8 
48.2 ± 2.0 
68.3 ± 0.7 
54.5 ± 0.8 
 
9  12.5 
25 
50 
100 
99.9 ± 4.8 
90.0 ± 1.6 
82.6 ± 2.7 
76.2 ± 1.1 * 
42.0 ± 1.2 
40.4 ± 0.7 
25.9 ± 2.3 
(−) 
7.5 ± 2.7 
11.0 ± 1.6 
42.9 ± 5.0 
(−) 
(−) 
The data were presented as mean ± S.D. 
### Compared with sample of control group. * p < 0.05, ** p < 0.01, 
and *** p < 0.001 were compared with LPS-alone group. (−): Not determined. Molecules 2013, 18 4482 
 
 
3. Experimental  
3.1. General Procedures 
Melting point was determined using an Electrothermal IA-9200 melting point measuring apparatus 
without correction. The UV spectrum was recorded on an Agilent UV-VIS recording 
spectrophotometer. The IR spectra (KBr) were obtained, on a Hitachi 270-30 type spectrometer. 
Optical rotations were measured with a Jasco DIP-1000 KUY polarimeter. The electrospray ionization 
(ESI) mass spectra were determined using an Agilent 1200 LC-MSD Trap spectrometer, and the   
HR-ESI-MS was completed with the aid of a Bruker APEX II mass spectrometer. 
1H- and 
13C-NMR, 
COSY, NOESY, HMQC, and HMBC spectra were recorded on a Bruker Avance-500 NMR 
spectrometer, using tetramethylsilane (TMS) as the internal standard. Standard pulse sequences and 
parameters were used for the NMR experiments and all chemical shifts were reported in parts per 
million (ppm, ). Column chromatography (CC) was performed on silica gel (Kieselgel 60, 70–230 mesh 
and 230–400 mesh, E. Merck, Darmstadt, Germany). 
3.2. Plant Materials 
The leaves of Annona reticulata L. (Annonaceae) were collected from Tiengiang, Vietnam, during 
October 2010 and the plant materials were identified and authenticated by Dr. Tran Huy Thai, Institute 
of Ecology and Biological Resources, Vietnamese Academy of Science and Technology. A voucher 
specimen (Viet-TSWu-20101015) was deposited at the Herbarium of the Vinh University. 
3.3. Extraction and Isolation 
The leaves of Annona reticulata L. (5.0 kg) were air-dried and powdered and soaked (24 h) with 
methanol (20 L × 3) at room temperature, and the combined extracts were concentrated under reduced 
pressure to give deep brown syrup (316.0 g). The crude extract was suspended into water (1 L) and 
partitioned with n-hexane (1 L × 5), ethyl acetate (1 L × 5), and n-butanol (1 L × 5), successively to 
afford  n-hexane (31.0 g), ethyl acetate (82.0 g), n-butanol (47.0 g), and water solubles (52.0 g), 
respectively, after removal of the corresponding solvent.  
The  n-hexane soluble extracts were purified by silica gel column chromatography eluted with   
n-hexane and acetone gradients to afford 14 fractions. Fraction 1 was subjected to silica gel column 
chromatography eluted with n-hexane/acetone (25:1) to yield kaurenoic acid (2, 968 mg). Fraction 2 
was isolated by silica gel column chromatography eluted with n-hexane/acetone (15:1) to afford 
taraxerol (3, 78 mg). Purification of fraction 3 by column chromatography with silica gel eluted by 
step gradients of n-hexane/acetone (15:1 and 9:1) afforded -sitosterol (4, 302 mg). Fraction 4 was 
subjected to silica gel column chromatography eluted with n-hexane/acetone (15:1) to yield   
16α-hydro-19-al-ent-kauran-17-oic acid (5, 26 mg). Fraction 5 was purified by silica gel column 
chromatography eluted with n-hexane/acetone (9:1) to yield 6β-hydroxystigmast-4-en-3-one (6,  
31 mg). Isolation of fraction 6 by column chromatography with silica gel eluted by n-hexane/acetone 
(7:1) yielded 17-acetoxy-16β-ent-kauran-19-oic acid (7, 22 mg). Silica gel column chromatography of Molecules 2013, 18 4483 
 
 
fraction 9 with step gradient elution of n-hexane/acetone (7:1 and 5:1) led to the purification of 
annonaretin A (1, 789 mg). 
The ethyl acetate soluble extracts were applied to silica gel column chromatography with 
chloroform and methanol gradients (20:1 to 5:1) to afford eight fractions. Fraction 1 was subjected to 
silica gel column chromatography eluted with n-hexane/acetone (9:1) to yield 16α-hydro-ent-kauran-
17,19-dioic acid (8, 38 mg). Silica gel column chromatography of fraction 6 with step gradient elution 
of chloroform and methanol (9:1 and 5:1) led to the isolation of (2S)-di-O-methylquiritigenin (9, 23 mg). 
3.4. Spectral Data 
Annonaretin A (1): colorless powder; m.p. 120−121 °C (CHCl3); 
1H-NMR (CDCl3) δ 0.40 (1H, d,  
J = 4.5 Hz, H-20), 0.62 (1H, d, J = 4.5 Hz, H-20), 0.78 (1H, m, H-6), 0.80 (3H, d, J = 9.5 Hz, CH3-32), 
0.82 (3H, s, CH3-18), 0.91 (3H, s, CH3-21), 0.93 (3H, d, J = 6.0 Hz, CH3-33), 0.97 (3H, s, CH3-22), 
0.98 (3H, s, CH3-19), 1.04 (1H, m, H-7), 1.10–1.20 (3H, m, H-1, -25, -16), 1.31–1.43 (7H, m, H-1,  
-12, -26, -5, -17, -25), 1.52–1.69 (9H, m, H-31, -11, -8, -15, -27, -6, -30, -16), 1.60 (3H, s, CH3-30), 
1.86–2.05 (3H, m, H-23, -26, -7), 3.01 (1H, d, J = 9.5 Hz, H-3), 3.40 (1H, br s, OH), 3.54 (1H, dd,  
J = 11.0, 6.0 Hz, H-24), 3.64 (1H, br dd, J = 16.0, 9.0 Hz, H-2), 3.70 (1H, br d, J = 11.0 Hz, H-24), 
4.64 (1H, br s, H-29), 4.77 (1H, br s, H-29); 
13C-NMR (CDCl3) δ 15.1 (C-18), 18.1 (C-19), 19.0  
(C-30), 19.2 (C-10), 19.3 (C-21), 20.7 (C-33), 20.9 (C-6), 21.3 (C-32), 25.1 (C-9), 25.7 (C-22), 25.7 
(C-1), 26.5 (C-7), 26.8 (C-16), 27.3 (C-26), 27.7 (C-25), 29.7 (C-20), 30.2 (C-31), 31.8 (C-15), 35.3 
(C-12), 39.7 (C-11), 40.3 (C-4), 43.1 (C-17), 45.0 (C-13), 46.2 (C-23), 47.1 (C-5), 47.7 (C-8), 48.7  
(C-14), 55.4 (C-27), 62.8 (C-24), 71.0 (C-2), 83.2 (C-3), 111.9 (C-29), 147.4 (C-28); ESI-MS m/z  
(rel. int.) 523 ([M+Na]
+, 100); HR-ESI-MS m/z 523.4122 [M+Na]
+
 (calcd for C33H56O3Na, 523.4127). 
3.5. Determination of Inhibitory Effects on NO Production 
3.5.1. Cell Culture 
A murine macrophage cell line RAW264.7 (BCRC No. 60001) was purchased from the Bioresources 
Collection and Research Center (BCRC) of the Food Industry Research and Development Institute 
(Hsinchu, Taiwan). Cells were cultured in plastic dishes containing Dulbecco’s Modified Eagle 
Medium (DMEM, Sigma, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS, 
Sigma, USA) in a CO2 incubator (5% CO2 in air) at 37°C and subcultured every 3 days at a dilution of 
1:5 using 0.05% trypsin–0.02% EDTA in Ca
2+-, Mg
2+- free phosphate-buffered saline (DPBS). 
3.5.2. Cell Viability 
Cells (2 × 10
5) were cultured in 96-well plate containing DMEM supplemented with 10% FBS for  
1 day to become nearly confluent. Then cells were cultured with samples in the presence of 100 ng/mL 
LPS for 24 h. After that, the cells were washed twice with DPBS and incubated with 100 μL of  
0.5 mg/mL MTT for 2 h at 37 °C testing for cell viability. The medium was then discarded and 100 μL 
dimethyl sulfoxide (DMSO) was added. After 30-min incubation, absorbance at 570 nm was read 
using a microplate reader (Molecular Devices, Sunnyvale, CA, USA). Molecules 2013, 18 4484 
 
 
3.5.3. Measurement of Nitric oxide/Nitrite 
NO production was indirectly assessed by measuring the nitrite levels in the cultured media and 
serum determined by a colorimetric method based on the Griess reaction [28]. The cells were 
incubated with a test sample in the presence of LPS (100 ng/mL) at 37 °C for 24 h. Then, cells were 
dispensed into 96-well plates, and 100 μL of each supernatant was mixed with the same volume of 
Griess reagent (1% sulfanilamide, 0.1% naphthyl ethylenediamine dihydrochloride, and 5% phosphoric 
acid) and incubated at room temperature for 10 min, the absorbance was measured at 540 nm with a 
Micro-Reader (Molecular Devices). By using sodium nitrite to generate a standard curve, the 
concentration of nitrite was measured form absorbance at 540 nm. 
3.5.4. Statistical Analysis 
Experimental results were presented as the mean ± standard deviation (SD) of three parallel 
measurements. Statistical comparisons were made by Student’s t-test. IC50 values were estimated using 
a non-linear regression algorithm (SigmaPlot 8.0; SPSS Inc. Chicago, IL, USA). Statistical 
significance is expressed as * p < 0.05, ** p < 0.01, and *** p < 0.001. 
4. Conclusion 
In summary, nine compounds were characterized from the leaves of A. reticulata L. and their 
inhibitory activity on NO production was examined. The results provide a potential explanation for the 
use of the leaves of A. reticulata as a herbal medicine in the treatment of inflammatory diseases, and 
they may be potentially useful in developing new anti-inflammatory agents. 
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